Improve Checkpoint-blockade Response in Advanced Urothelial Cancer
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Clinical Trials Related to Urothelial Carcinoma
Related studies linked through entity extraction aliases.
Study Evaluating the Efficacy and Safety of Multiple Immunotherapy-Based Treatments and Combinations in Patients With Urothelial Carcinoma (MORPHEUS-UC)
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
A Study of XmAb®22841 Monotherapy & in Combination w/ Pembrolizumab in Subjects w/ Selected Advanced Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE1
FT500 as Monotherapy and in Combination With Immune Checkpoint Inhibitors in Subjects With Advanced Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE1
TPST-1120 as Monotherapy and in Combination With Nivolumab in Subjects With Advanced Cancers
- Status
- COMPLETED
- Phase
- PHASE1
Famitinib Plus Anti-PD1 Therapy for Advanced Urinary System Tumor, Advanced Gynecological Tumors
- Status
- UNKNOWN
- Phase
- PHASE2
A Open-label, Single-arm, Multicenter, Phase II Study of RC48-ADC to Evaluate the Efficacy and Safety of Subjects With HER2 Overexpressing Locally Advanced or Metastatic Urothelial Cancer
- Status
- COMPLETED
- Phase
- PHASE2
A Study of Personalized Neoantigen Cancer Vaccines
- Status
- COMPLETED
- Phase
- N/A
Water Versus Saline as Irrigation Fluid for Ureteroscopy
- Status
- COMPLETED
- Phase
- NA
Prevalence of PD-L1 Expression in Patients With Advanced Urothelial Carcinoma
- Status
- COMPLETED
- Phase
- N/A
A Study Investigating the Outcomes and Safety of Atezolizumab Under Real-World Conditions in Patients Treated in Routine Clinical Practice
- Status
- COMPLETED
- Phase
- N/A
IRX-2 Regimen Combined With Nivolumab in Recurrent/Metastatic Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE1
A Study of XmAb®23104 in Subjects With Selected Advanced Solid Tumors (DUET-3)
- Status
- COMPLETED
- Phase
- PHASE1
Trial of Atezolizumab Plus Chemotherapy After Progression on PD-1 or PD-L1 in Cisplatin-ineligible Patients With Advanced Urothelial Carcinoma
- Status
- TERMINATED
- Phase
- PHASE2
A Study to Evaluate ONM-100, an Intraoperative Fluorescence Imaging Agent for the Detection of Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Arginase-1 Peptide Vaccine in Patients With Metastatic Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE1
Predictive Factorsfor Final Pathologic Ureteral Sections
- Status
- COMPLETED
- Phase
- N/A
A Clinical Study of PD-L1 Antibody ZKAB001（Drug Code） in Locally Advanced and Metastatic Urothelial Carcinoma
- Status
- UNKNOWN
- Phase
- PHASE1/PHASE2
A Safety and Tolerability Study of NC318 in Subjects With Advanced or Metastatic Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Trial of Mitomycin C During Nephroureterectomy for Urothelial Carcinoma
- Status
- COMPLETED
- Phase
- PHASE2